Symptomatic COVID-19 Infection Laboratory-Confirmed

14 clinical trials · Condition

Record	Firm	Date
Lopinavir/Ritonavir for the Treatment of COVID-19 Positive Patients With Cancer and Immune Suppression in the Last Year (NCT04455958)	OHSU Knight Cancer Institute	2021-05-01
Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy (NCT04532372)	City of Hope Medical Center	2021-01-07
Viral Specific T Cell Therapy for COVID-19 Related Pneumonia (NCT04742595)	M.D. Anderson Cancer Center	2020-12-18
Ibrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 2019 (COVID-19) (NCT04665115)	Academic and Community Cancer Research United	2020-11-23
Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients (NCT04379518)	Roswell Park Cancer Institute	2020-11-17
Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization (NCT04439006)	Jennifer Woyach	2020-10-23
Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia (NCT04565665)	M.D. Anderson Cancer Center	2020-07-29
Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19 (NCT04433949)	Emory University	2020-06-23
Tocilizumab for Patients With Cancer and COVID-19 Disease (NCT04370834)	National Cancer Institute (NCI)	2020-05-28
Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19 (NCT04373044)	University of Southern California	2020-05-01

Every clearance here is in the API, with alerts when new ones post.